Who
Jereme M. Sylvain
EVP, Chief Financal Officer
Company insider
Files Form 4 as: EVP, Chief Financal Officer, DexCom; Chief Accounting Officer, Nuvasive.
In numbers
- Trades disclosed
- 76
- Buys
- 0
- Sells
- 29
- Bought
- $0
- Sold
- $9.3M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 1 Feb 2017
- Last trade
- 10 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 14 Sep 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $303K3,638 at $83.27 | filing |
| 10 Sep 2026filed 14 Sep 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $303K3,638 at $83.27 | filing |
| 22 Aug 2026filed 25 Aug 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $134K1,451 at $92.34 | filing |
| 22 Aug 2026filed 25 Aug 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $134K1,451 at $92.34 | filing |
| 22 May 2026filed 27 May 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $104K1,451 at $71.90 | filing |
| 22 May 2026filed 27 May 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $104K1,451 at $71.90 | filing |
| 8 Mar 2026filed 10 Mar 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —48,774 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $1.3M18,950 at $68.10 | filing |
| 8 Mar 2026filed 10 Mar 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —48,774 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $1.3M18,950 at $68.10 | filing |
| 29 Jan 2026filed 2 Feb 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —7,123 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $195K2,652 at $73.36 | filing |
| 29 Jan 2026filed 2 Feb 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —7,123 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $195K2,652 at $73.36 | filing |
| 2 Sep 2025filed 4 Sep 2025 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $358K4,824 at $74.17 | filing |
| 12 Mar 2025filed 14 Mar 2025 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $845K12,001 at $70.38 | filing |
| 10 Mar 2025filed 11 Mar 2025 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $195K2,670 at $73.22 | filing |
| 10 Mar 2025filed 11 Mar 2025 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $237K3,203 at $74.04 | filing |
| 10 Mar 2025filed 11 Mar 2025 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $84K1,127 at $74.70 | filing |
| 8 Mar 2025filed 11 Mar 2025 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —35,906 at $0.00 | filing |
News
DexCom, Inc. $DXCM Position Lowered by Gradient Investments LLCDXCM · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Jereme M. Sylvain; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.